UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	February 27, 2019

Accession Number:	0001144204-19-008163
Submission Type:	POS AM
CIK: 0001649989 Company Name: Outlook Therapeutics, Inc. File Number: 333-209011